Long-Term Effectiveness of a Monofocal Intraocular Lens (IOL) Enhanced for Intermediate Vision: A 5-Year Follow-Up Study
Journal of Clinical Medicine · 18.08.2025 · 14 (16) · 5831
DOI: 10.3390/jcm14165831 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 18.08.2025. Verfasst von Rita Mencucci und 5 weiteren Autor:innen. Beteiligte Einrichtung: Eye Clinic, Department of Neuroscience, Psychology, Pharmacology and Child Health (NEUROFARBA), University of Florence, Largo Brambilla 3, 50134 Flor…. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: The Tecnis Eyhance is an enhanced monofocal intraocular lens (IOL) designed to improve intermediate vision without compromising distance clarity or increasing the incidence of photic phenomena. Although short-term results have been encouraging, long-term data remain limited. This study presents the 5-year follow-up of a previously published 6-month clinical evaluation, aiming to assess the stability of visual, optical, and patient-reported outcomes over time.
Methods
A single-center retrospective study of 18 patients (36 eyes) undergoing bilateral Tecnis Eyhance IOL implantation was conducted. The same cohort from the original 6-month study was re-evaluated after a mean follow-up of 5 years. Visual acuity (distance, intermediate, near), defocus curves, contrast sensitivity, optical quality, effective lens position (ELP), halo size, and patient-reported measures were assessed.
Results
Visual acuity remained stable across all distances, with binocular uncorrected intermediate visual acuity (UIVA) ≤ 0.2 logMAR in all patients. No significant changes were observed in optical quality parameters or contrast sensitivity. ELP remained consistent over time (p = 0.298), and posterior capsule opacification (PCO) requiring Nd:YAG capsulotomy developed in 5% of the eyes. Halo size was mild, and subjective glare perception did not increase. Spectacle independence remained high for distance (100%) and intermediate (more than 75%) tasks.
Conclusions
This 5-year follow-up study confirms the long-term stability and effectiveness of the Tecnis Eyhance IOL. These findings support its long-term use as a stable monofocal IOL with enhanced intermediate function.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Eye Clinic, Department of Neuroscience, Psychology, Pharmacology and Child Health (NEUROFARBA), University of Florence, Largo Brambilla 3, 50134 Florence, Italy.
- Unit of Ophthalmology, Department of Medicine, Surgery and Neuroscience, University of Siena, Viale Mario Bracci 16, 53100 Siena, Italy.
ORCID-Profile: Rita Mencucci, Giovanni Romualdi, Alberto Carnicci, Matilde Buzzi, Fabrizio Giansanti
Zitieren
APA
Mencucci, R., Romualdi, G., Carnicci, A., Panini, F., Buzzi, M., & Giansanti, F. (2025). Long-Term Effectiveness of a Monofocal Intraocular Lens (IOL) Enhanced for Intermediate Vision: A 5-Year Follow-Up Study. Journal of Clinical Medicine, 14(16), 5831. https://doi.org/10.3390/jcm14165831
Vancouver
Mencucci R, Romualdi G, Carnicci A, Panini F, Buzzi M, Giansanti F. Long-Term Effectiveness of a Monofocal Intraocular Lens (IOL) Enhanced for Intermediate Vision: A 5-Year Follow-Up Study. Journal of Clinical Medicine. 2025;14(16):5831. doi:10.3390/jcm14165831
BibTeX
@article{Mencucci2025,
author = {Mencucci, Rita and Romualdi, Giovanni and Carnicci, Alberto and Panini, Fabio and Buzzi, Matilde and Giansanti, Fabrizio},
title = {Long-Term Effectiveness of a Monofocal Intraocular Lens (IOL) Enhanced for Intermediate Vision: A 5-Year Follow-Up Study},
journal = {Journal of Clinical Medicine},
year = {2025},
volume = {14},
number = {16},
pages = {5831},
doi = {10.3390/jcm14165831}
}
EUVIMED